Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Meifeng Yin
microRNA-605 Directly Targets SOX9 to Alleviate the Aggressive Phenotypes of Glioblastoma Multiforme Cell Lines by Deactivating the PI3K/Akt Pathway
OncoTargets and Therapy
Oncology
Pharmacology
Related publications
MicroRNA-761 Targets FGFR1 to Suppress the Malignancy of Osteosarcoma by Deactivating PI3K/Akt Pathway
OncoTargets and Therapy
Oncology
Pharmacology
MicroRNA-511 Inhibits Malignant Behaviors of Breast Cancer by Directly Targeting SOX9 and Regulating the PI3K/Akt Pathway
International Journal of Oncology
Cancer Research
Oncology
MicroRNA‑448 Inhibits the Progression of Retinoblastoma by Directly Targeting ROCK1 and Regulating PI3K/AKT Signalling Pathway
Oncology Reports
Medicine
Cancer Research
Oncology
MicroRNA-145 Inhibits Growth of Laryngeal Squamous Cell Carcinoma by Targeting the PI3K/Akt Signaling Pathway
Cancer Management and Research
Oncology
MicroRNA‑766 Inhibits Papillary Thyroid Cancer Progression by Directly Targeting Insulin Receptor Substrate 2 and Regulating the PI3K/Akt Pathway
International Journal of Oncology
Cancer Research
Oncology
MicroRNA‑138 Suppresses Cell Proliferation and Invasion of Renal Cell Carcinoma by Directly Targeting SOX9
Oncology Letters
Cancer Research
Oncology
TLK2 Enhances Aggressive Phenotypes of Glioblastoma Cells Through the Activation of SRC Signaling Pathway
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
microRNA‑574 Inhibits Cell Proliferation and Invasion in Glioblastoma Multiforme by Directly Targeting Zinc Finger E‑box‑binding Homeobox 1
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
LIM and SH3 Protein 1 Regulates Cell Growth and Chemosensitivity of Human Glioblastoma via the PI3K/AKT Pathway
BMC Cancer
Cancer Research
Oncology
Genetics